Submissions

Online Submissions

Already have a Username/Password for Medicine and Biotechnology?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required for submitting items online, and for checking the status of current submissions.

 

Author Guidelines

The Journal "Medicine and Biotechnology" publishes the results of original scientific completed research that contribute to the development of science in the field of medicine and biotechnology. The Journal may present articles on clinical, clinical-experimental and fundamental research, systematic reviews, descriptions of clinical cases, discussion materials, translations of foreign medical periodicals, as well as auxiliary materials. Original scientific articles in Russian and English that correspond to the profile of the Journal are accepted.

The primary objective of the Journal is to publish original research, descriptions of innovative methods or technologies that are unconditionally novel and significant for medicine or biotechnology, the results of research involving people; to a lesser extent, the Journal is devoted to in vitro research and experiments involving animals. The Journal does not publish experimental and clinical studies on the use of dietary supplements.

Original research should be designed in accordance with the IMRAD format.

The editorial board strongly recommends observing the following standards for the presentation of their scientific research, depending on its type:

  • parallel group randomized trials – CONSORT standard;
  • observational studies – STROBE standard;
  • clinical trials – SPIRIT standard;
  • diagnostic accuracy studies – STARD standard;
  • clinical case reporting – CARE standard;
  • clinical practice guidelines – AGREE standard;
  • qualitative research – SRQR standard;
  • preclinical animal studies – ARRIVE standard;
  • quality improvement reporting SQUIRE standard;
  • health economic evaluation reporting – CHEERS standard.

All clinical and preclinical studies must be approved by the ethics committee.

All studies involving vulnerable population should be conducted in accordance with international ethical principles.

The conclusion of the ethics committee is obligate if any biomaterials were collected.

The editorial board has the right to request from the authors a copy of the conclusion of the ethics committee. Researchers must obtain voluntary informed consent from patients or their legal representatives to participate in the study.

Consent form-must be approved by the ethics committee.

The journal publishes review papers, including:

  • systematic reviews of research in various areas of the journal and related disciplines,
  • analyzes of literary sources on a given topic,
  • summaries of the currently existing points of view.

Reviews should comply with international guidelines for systematic literature search methods and standards – the PRISMA standard. Review articles should contain complete information about methods of searching literature in databases of a multidisciplinary and specialized profile.

Clinical and experimental studies described in manuscripts must comply with accepted international principles of ethics and deontology. The editors of the journal ask to clearly describe in manuscripts that the study was conducted in accordance with international GCP standards (voluntary signing of informed consent by all study participants, review of the study protocol by the ethics committee indicating the name of the LEC, date of the meeting and protocol number, etc.). The description of the work should provide the study protocol in as much detail as possible: so detailed that it could be fully reproduced. When submitting a meta-analysis to the editor, the procedure for searching for information sources should be described in detail: database names, filters and keywords, as well as all additional conditions for selecting primary sources.

The journal accepts for publication descriptions of clinical cases, articles on the history of medicine and reports on important events in the field of medicine and biotechnology. The text of a short report can be structured into sections and parts – at the discretion of the authors.
When sending an article to the editors, it is recommended to follow the rules drawn up taking into account the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" developed by the International Committee of Medical Journal Editors.
It is not allowed to send to the editors already published articles or articles sent for publication to other journals. In case of detection of simultaneous submission of a manuscript to several publications, the published article will be retracted (retracted from publication). Monitoring of unauthorized citation is carried out using the "Antiplagiat" system. In case of detection of multiple borrowings, the editors act in accordance with the COPE rules.
Particular attention should be paid to the quality of the translation (American or British English is acceptable, but not a combination of the two). It is preferable that the translation be done by a native English speaker. To eliminate possible grammatical or spelling errors and ensure compliance with correct scientific English, we recommend using an English editing service.

The article and all accompanying materials should be sent only via the electronic form on the journal's website: https://medbiosci.ru/MedBiotech/index (SUBMIT ARTICLE button). You need to register first. After uploading the manuscript to the editors, the corresponding author will receive a notification of its registration. If no notification is received within 24 hours, you will need to clarify whether the article has arrived by writing to an e-mail medbiosci@mail.ru or calling the editors.
Submission of an article to the journal implies that the manuscript:
• has not been previously published in another journal;
• is not under consideration in another journal;
• all co-authors agree to the publication of the article;
• consent has been obtained – implicit or explicit – from the organization where the study was conducted.
When submitting a manuscript to the journal, authors must ensure that all citations are formatted correctly, sources for tables and figures are indicated (unless otherwise stated, it is assumed that the tables and figures were created by the author).

Manuscript text format. The editors accept texts saved in .doc, .docx, .rtf formats. It is advisable to use Times New Roman font, 14 font size and 1.5 line spacing. Manual hyphenation is not allowed. Double spaces and unnecessary line breaks must be removed from the text (automatically via the Microsoft Word "find and replace" service). When formatting the manuscript text, do not use underlining within the text (use bold for subheadings, italics for highlighting in the text); foreign names (of journals, organizations, etc.) should be left in the original, enclosed in quotation marks. The volume of the full text of the manuscript, including tables and references, should not exceed 6,000 words for original research, and 10,000 words for reviews. The volume of articles devoted to the description of clinical cases is no more than 4,000 words; short communications – within 1,500 words. The number of words in the text can be found through the Word menu (File – View document properties – Statistics). The structure of the manuscript should correspond to the recommendations below (depending on the type of work).

Article Element

Recommendations for Content and Design

Title Page

Please provide the following information in Russian and English:

- full name of the authors;

- official name of the organization without abbreviations, city and country;

- detailed information about the authors: degree, title, position and additional information at the author’s request;

- e-mail and telephone number of all authors with the corresponding author indicated;

- article type;

- article title;

- abstract (it should not contain undeciphered abbreviations or terms introduced for the first time);

- keywords.

Headline

The headline of the article should briefly (no more than 10 words) and accurately reflect the content of the article, the subject matter and the results of the scientific research. It is necessary to include both information content and attractiveness, the uniqueness of the author's scientific work. It is given in Russian and English.

Annotation

It is necessary to adhere to the IMRAD (Introduction, Methods, Results, Discussion) format unless the selected manuscript genre suggests a different structuring. The given parts of the annotation should be highlighted with appropriate subheadings and present relevant information in these sections. The recommended annotation length is 200–250 words. It should be provided in Russian and English.

The following components should be clearly identified in the annotation:

Introduction (1–3 sentences). Please justify the relevance and novelty of your study based on the importance of the problem (e.g., use epidemiological indicators) and the remaining gaps in this area of ​​knowledge.

Purpose of the study. Formulate as specifically as possible the research question for which the study was conducted.

Materials and methods. This section of the abstract should contain brief information about the target population (one or more), study design, characteristics of the intervention (if used), the main studied indicators and methods for their assessment. If the study is registered in the clinical trials register, provide the registration number. Provide information about the object and the sequence of the study. All non-traditional modifications of methods should be described in sufficient detail. For all reagents, animals, cell cultures, etc. used in the work, it is necessary to accurately indicate the manufacturers and/or sources of receipt (with the names of the country, company, institution). Specify the number of study participants (the number included in the study, those who completed it (for prospective studies), the most significant characteristics of the formed groups).

Study results. Provide specific key authorial results of the study – descriptive statistics of the most important indicators, the results of testing statistical hypotheses in relation to them, 95% confidence intervals for the main results. Probability values ​​​​should be presented with three decimal places. If there is data on adverse events associated with medical intervention, they must be mentioned. The results of the study are described in a logical sequence in the form of separate fragments separated by subheadings (optional), without elements of discussion, without repeating methodological details, without duplicating digital data given in tables and figures.

Discussion and conclusion. Briefly and as accurately as possible formulate conclusions based on the results obtained, indicate the practical significance and prospects of the study.

The given parts of the abstract should be highlighted with appropriate subheadings and relevant information should be presented in these sections. Provided in Russian and English.

Keywords

They are a search image of a scientific article. All bibliographic databases allow searching articles by keywords. In this regard, they should reflect the design of the scientific research, the main provisions, achievements, results and terminology. The recommended number of keywords is 5–10. Provided in Russian and English.

Funding

Information on funding is provided in Russian and English.

Acknowledgments

This section should mention people who helped the author prepare this article, organizations that provided financial support. This section can be used to express gratitude to anonymous reviewers. Provided in Russian and English.

Information about conflicts of interest

The article should indicate a real or potential conflict of interest. If there is no conflict of interest, it should be written that “the author declares that there is no conflict of interest”. Please note that the presence of an obvious or potential conflict of interest (including the financial interest of the authors) or the participation of any organizations (public or private) in conducting the research and writing the work is NOT a reason to refuse to publish the manuscript. On the contrary, this information will indicate the openness of the authors and the reliability of the results, which will give the manuscript additional advantages at the stage of evaluation by reviewers and will generate greater interest and trust among readers. Provided in Russian and English.

MAIN TEXT

The main text of the empirical article is presented in Russian or English in a specific sequence:

1) Introduction;

2) Materials and Methods;

3) Results;

4) Discussion and Conclusion.

These parts must be highlighted with appropriate subheadings and relevant information must be presented in these sections.

1) Introduction. Justify the relevance of the study based on the importance of the problem. For this purpose, use, for example, epidemiological indicators (prevalence, incidence, mortality, disability, fatality, quality of life, QALY, DALY, etc.), the socioeconomic burden of the disease, etc. You can provide the values ​​of these indicators at the global, continental, country, and regional levels. Justify the novelty of your study by describing the remaining gaps in this area of ​​knowledge. Identify resolved and unresolved (or resolved at an insufficiently high methodological level) aspects of the problem (different population, different intervention, different evaluation criteria or methods, etc.) with an analysis of previously published results (Russian, foreign). Each statement by the authors, with the exception of the most well-known, should be accompanied by references to sources of information.

It is necessary to describe the main modern studies and publications on which the author relies; modern views on the problem; difficulties in developing this topic; highlighting unresolved issues within the general problem to which the article is devoted. It is advisable to consider a sufficient number of sources and compare the views of the authors. It is important to conduct a comparative analysis with foreign publications on the stated problem.

The introduction should express the main idea of ​​the publication, which differs significantly from modern ideas about the problem, complements or deepens already known approaches to it; attention is drawn to the introduction of new facts, conclusions, recommendations, and patterns into scientific circulation. The purpose of the article follows from the formulation of the scientific problem. Make sure that the formulations of the purpose in the main text and in the abstract coincide.

2) Materials and Methods (1–2 pages). This section describes the design of the study, the process of organizing the experiment, the methods used, the equipment used; provides detailed information about the object of study; indicates the sequence of the study and justifies the choice of the methods used (observation, survey, testing, experiment, laboratory experience, analysis, modeling, etc.).

3) Results. This part of the article should present the author’s systematized analytical and statistical material. The results of the study should be described in sufficient detail so that the reader can follow its stages and assess the validity of the author’s conclusions. This is the main section, the purpose of which is to prove the working hypothesis (hypotheses). The results are supported, if necessary, by illustrations (tables, graphs, drawings) that present the original material or evidence in a condensed form. It is important that the illustrated information does not duplicate that already given in the text. It is desirable to compare the results presented in the article with previous works in this area by both the author and other researchers. Such a comparison will additionally reveal the novelty of the work performed and give it objectivity. The results of the study should be presented briefly, but at the same time contain enough information to evaluate the conclusions made. It should also be substantiated why these data were chosen for analysis.

4) Discussion and Conclusion. The conclusion contains a brief formulation of the research results. It summarizes the main ideas of the main part of the work. It is necessary to compare the obtained results with the goal stated at the beginning of the work. The conclusion summarizes the results of understanding the topic, draws conclusions, generalizations and recommendations arising from the work, emphasizes their practical significance, and determines the main directions for further research in this area. It is desirable to include attempts to predict the development of the issues considered in the final part of the article.

Tables

Each table is placed immediately after the paragraph where it is first referenced. There should be no empty columns in tables. Tables are numbered in Arabic numerals separately from the numbering of figures. The title is printed above the table. All titles, captions and structural elements of graphs, tables, diagrams, etc. are written in Russian and English. Units of measurement, if necessary, are included in the headings of rows or columns.

Figures

Figures should be presented in raster or vector format with a resolution of at least 300 dpi. They should allow text editing and the ability to change sizes. The use of scanned images in the form of dependencies, graphs, design elements, etc. is undesirable or must be justified. All graphic data is placed in the text of the article, and sent additionally as separate files. In the text of the article, the titles of the figures (graphs, photographs) are placed immediately after the paragraph where the first reference to them is given. All figures are numbered sequentially with Arabic numerals as they are used in the text of the article. The title is printed under the figure. Figure captions are brief but informative. The fonts inside the figures are selected from the Times New Roman fonts, the font size should allow easy reading of the inscriptions. Inscriptions in the Roman alphabet are in italics, in Russian – in upright. Figures in the article must match the sent source files. The titles of the figures and notes to them, captions, and legend text must be translated into English and placed under the corresponding text on a new line. Illustrations of different types must be brought to a single style of graphic execution, observing the uniformity of their design. Graphs, charts, and diagrams must be designed in Microsoft Excel. If an electronic graphic image is created in Microsoft Office applications (Word, PowerPoint, Excel, Visio), Corel Draw, or Adobe Illustrator, it must be submitted “as is” in the same format (doc, docx, ppt, pptx, xls, xlsx, vsd, vsdx, cdr, ai, eps). Diagrams and graphs provided in these files must be editable. If a figure (table, photograph) has previously been published elsewhere (including in your own works), you must indicate the original source and obtain written permission from the copyright holder to reproduce the figure, with the exception of documents in the public domain.

Formulas

Formulas are typed in a combination of the main font and the Symbol font (except for fractions, sums, and square roots) in Math Type 6. Scanned formulas or formulas in the form of figures are not accepted. Latin characters in formulas and notations (both in the text and in figures) are typed in italics. Formulas are numbered in parentheses. Only those formulas and equations that are referenced in the subsequent presentation should be numbered. Numbered formulas must be centered, with the formula number in parentheses placed at the right edge of the page. The article should not be cluttered with complex formula expressions. The necessary transformations should be compact and understandable for readers.

Designations, abbreviations and units of measurement

All abbreviations must be expanded upon first use. If there are many abbreviations, a list with the expansion of each of them must be made before the text of the article. For complex terms or names most frequently used in the text of the article, no more than 3-5 non-traditional abbreviations may be entered (in parentheses after the first mention of the full name of the term). Abbreviations legalized by international nomenclatures are used in the corresponding transcription. Names of microorganisms are given in the original transcription using italics (E. coli, Streptococcus pyogenes). Units of measurement are given without a period after their abbreviated designation (s, h, cm, ml, mg, µm, kDa, etc.), regulated by international rules.

Footnotes

If necessary, footnotes with continuous numbering (Arabic numerals) are used throughout the document. Footnotes may contain citations from works that are mentioned in the text, additional information. If it is necessary to refer to an article in a socio-political newspaper, text on a website or blog, clinical guidelines, an abstract, a textbook, then information about the source should be placed in a footnote.

Design of quotations

The journal uses the Vancouver style of citation (reference in the text in square brackets, full bibliographic description of the source in the bibliography in the order of mention in the text of the article).

References 

They are prepared in Russian and English. The list of references includes only peer-reviewed sources (articles from scientific journals and monographs) mentioned in the text of the article. The number of sources should not exceed 50 in an empirical article and 100 in a review article.

References to articles accepted for publication but not yet published should be marked with the words “in press”; authors must obtain written permission to reference such documents and confirmation that they have been accepted for publication. Information from unpublished sources should be marked with the words “unpublished data / documents”; authors must also obtain written confirmation of the use of such materials.

Bibliographic descriptions of references should be written in Vancouver format in the AMA version (AMA style, http://www.amamanualofstyle.com).

If the article is written in Latin (in German, Finnish, Danish, Italian, etc.), it should be cited in the original form:

Examples:

1.      Brodovskaya E.P., Zaslavskaya K.Ya., Ayub A.M.Al.H., et al. In Vitro Study of the Cytotoxic and Immunotropic Effects of Molnupiravir and Favipiravir. Pharmaceutical Chemistry Journal. 2024;57(11):1693-1697. https://doi.org/10.1007/s11094-024-03066-5

2.      Escribano-Subías P. La enfermedad de Whipple crónica, un reto diagnóstico para el cardiólogo. Revista Española de Cardiología. 2023;(12):954-955. (In Span.) https://doi.org/10.1016/j.recesp.2023.06.012

 

Bibliographic descriptions of references to Russian-language sources should consist of two parts: Russian and Latin (in succession). In this case, the Russian-language part of the description should be given first, then the Latin-language part.

 

Surname, Initials. Title of the article. Title of the journal. Year; Volume (number):Pages. https://doi.org/10.19163/2307-9266-2023-11-5-412-421

Пример:

1.      Королева А. А., Герасимов С. С., Любченко Л. Н. Генетические факторы тромбоза FII G20210A, FV G1691A (Arg506Gln) у больных со злокачественными опухолями торакоабдоминальной локализации. Успехи молекулярной онкологии. 2024;11(1):105–112. https://doi.org/10.17650/2313-805X-2024-11-1-105-112

Korolyova A.A., Gerasimov S.S., Lyubchenko L.N. Genetic Factors of Thrombosis FII G20210A, FV G1691A (Arg506Gln) in Patients with Thoracoabdominal Malignant Tumors. Uspekhi molekulyarnoy onkologii – Advances in Molecular Oncology. 2024;11(1):105–112. (In Russ., abstract in Eng.) https://doi.org/10.17650/2313-805X-2024-11-1-105-112

 

4 and more authors

Surname, Initials, Surname, Initials, Surname, Initials, et al. Title of the article. Title of the journal. Year; Volume (number):Pages. https://doi.org/10.15690/pf.v21i1.2708

Examples:

1.    Васичкина Е. С., Балыкова Л. А., Басаргина Е. Н. и др. Миокардиты у детей. Этиология. Патогенез. Эпидемиология. Клиническая картина. Педиатрическая фармакология. 2024;21(1):50–61. https://doi.org/10.15690/pf.v21i1.2708

Vasichkina E.S., Balykova L.A., Basargina E.N., et al. Myocarditis in Children. Etiology. Pathogenesis. Epidemiology. Clinical Presentation. Pediatricheskaya Farmakologiya – Pediatric Pharmacology. 2024; 21(1):50–61. (In Russ., abstract in Eng.) https://doi.org/10.15690/pf.v21i1.2708

2.    Школьникова М. А., Шубик Ю. В., Шальнова С. А. и др. Сердечные аритмии у лиц пожилого возраста и их ассоциация с характеристиками здоровья и смертностью. Вестник аритмологии. 2007;(49):5–13. URL: https://vestar.elpub.ru/jour/article/view/317 (дата обращения: 00.00.2025).

Shkolnikova M.A., Shubik Yu.V., Shalnova S.A., et al. Cardiac Arrhythmias in Elderly Patients and Their Correlation with Health Indices and Mortality. Journal of Arrhythmology. 2007;(49):5–13. (In Russ., abstract in Eng.) Available at: https://vestar.elpub.ru/jour/article/view/317 (accessed 00.00.2025).

 

Patent reference

Surname and initials of the inventors; Title of the invention. Document type designation, number, country name, international classification index of inventions. Publication date, information about the published document. Application registration number; Filing date.

Example:

Туркова Н. И., Матвеева Л. В., Голикова А. С., Аль-Захар Н. Б. А. Способ иммунологического прогнозирования внезапной коронарной смерти. Патент на изобретение РФ № 2810015 С1. Опубл. 21.12.2023 г., Бюл. № 36. Заявка №2023121762 от 21.08.2023.

Turkova N.I., Matveeva L.V., Golikova A.S., Al-Zahar N.B.A. Method for immunological prediction of sudden coronary death. Patent for invention of the Russian Federation No. 2810015 C1. Published 12/21/2023, Bulletin No. 36. Application No. 2023121762 dated 08/21/2023 (in Russ).

 

 Footnotes

 Links to a chapter from a book

Surname, Initials. Chapter title // Book title. City : Publishing House, year. Pages. https://doi.org/10.1007/978-981-99-1191-2_4

Example:

Engstrand, L. Bacterial species as partners and pathogens // Editors: P. J. Heidt, T. Midtvedt, V. Rusch, J. Versalovic. – Old Herborn University Foundation, Herborn-Dill, Germany. 2012. P. 45-52.

 

Links to the monograph

Surname, Initials. [Title]. City: Publishing House, year. Pages. URL: (date of access:         ).

Example:

Соколова Г. Н., Потапова В. Б. Клинико-патогенетические аспекты язвенной болезни желудка : моногр. М. : Анахарсис, 2009. 328 с.

Sokolovа G.N., Pоtapova V.B. [Clinical and pathogenetic aspects of gastric ulcer]. Мoscow: Аnachаrsis, 2009. 328 p. (in Russ.)

 

Link to the dissertation abstract

Example:

Хрыков, Г. Н. Роль опухолевых маркеров в диагностике метастазов рака желудка и толстой кишки : автореф. дисс. … к.м.н. : 14.00.27, 14.00.46 / Хрыков Глеб Николаевич. – СПб., 2007. – 16 с.

Khrykov, G.N. The role of tumor markers in the diagnosis of metastases of gastric and colon cancer : author’s abstract. diss. … candidate of medical sciences: 14.00.27, 14.00.46 / Khrykov Gleb Nikolaevich – St. Petersburg, 2007. 16 p.

 

Links to regulatory documents

Name of the normative act [Electronic resource] : type, date and number: adopted by whom and when. URL: http://www.kremlin.ru/acts/bank/46328 (date of access: 10.03.2022).

Example:

Об утверждении Порядка оказания медицинской помощи взрослому населению при онкологических заболеваниях (с изменениями и дополнениями) [Электронный ресурс] : приказ Министерства здравоохранения РФ от 19.02.2021 г. N 116н. URL: https://base.garant.ru/400533605/ (дата обращения: 10.01.2025).

On approval of the Procedure for the provision of medical care to the adult population with oncological diseases (with amendments and additions) [Electronic resource] : order of the Ministry of Health of the Russian Federation dated 02/19/2021 N 116n. URL: https://base.garant.ru/400533605/ (date accessed: 01/10/2025).

 

Link to electronic resource

Resource name : website [Electronic resource]. URL: (date of access: 03/10/2022).

Example:

Хроматографические методы анализа : сайт [Электронный ресурс]. URL: https://www.meta-chrom.ru/company/articles/chromatographic-analysis-methods/ (дата обращения: 10.01.2025).

Chromatographic methods of analysis : website [Electronic resource]. URL: https://www.meta-chrom.ru/company/articles/chromatographic-analysis-methods/ (date of access: 10.01.2025).

 

Contributions of co-authors

To formulate the actual contribution of each co-author to the completed work, it is necessary to use the CRediT (Contributor Roles Taxonomy) taxonomy – a standard developed by the National Information Standards Organization, NISO (https://credit.niso.org/). The order of indicating the authors and co-authors of the article is agreed upon by them independently. It is given in Russian and English.

 

 

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with each of the following items, and submissions that do not adhere to these guidelines may be returned to the authors.

    • This article has not been previously published or submitted for consideration and publication in another journal (otherwise, please explain this in Notes to the Editor).
    • The submitted manuscript file must be in Microsoft Word or RTF format – *.doc, *.docx, *.rtf.
    • Internet links must be provided as full URLs.
    • The text must be typed with 1.5 line spacing, Times New Roman font, 14 pt; emphasis must be in italics, not underlined (except for Internet links); all illustrations, graphs, and tables must be located in the text where they are meaningful (not at the end of the document).
    • The text complies with the stylistic and bibliographic requirements of the Guidelines for Authors, located in the About Us section.
    • The authors’ names have been removed from the article title and other requirements of the Ensuring Anonymity in Peer Review document have been met.
 

Copyright Notice

Federal State Budgetary Educational Institution of Higher Education "National Research Ogarev Mordovia State University", hereinafter referred to as the "Licensee", on the one hand, and citizens of , hereinafter referred to as the "Licensor", on the other hand, hereinafter referred to as the "Party / Parties" have entered into this agreement (hereinafter referred to as "Agreement") as follows.

 

  1. Subject matter of the Agreement

1.1. Under this Agreement, the Licensor grants the Licensee, free of charge, the right to use the Editorial Board of the Medicine and Biotechnology,

 (name and characteristics of the materials to be transferred)

hereinafter referred to as "Work", on a non-exclusive license within the limits and for the term set forth in the Agreement.

1.2. The Licensor warrants that it has exclusive copyright in the Work transferred to the Licensee.

1.3. The Licensor guarantees that the transfer of the rights to the Work and its further use by the Licensee in accordance with this Agreement, will not lead to a violation of the rights of third parties. This warranty also implies the written consent of the authors of the Work, as well as of the persons who are the owners or other legal owners of the equipment, software and/or hardware, technical means, materials and others involved by the author and/or the Licensor in the creation of the Work and/or depicted in the Work, to the performance by the Licensor of the obligations provided for in this Agreement, in particular to the transfer of the rights to the Work to the Licensee.

1.4. The Licensor guarantees that during the creation of the Work and the subsequent transfer of rights to it to the Licensee confidential information (state, official, trade secrets) will not be violated.

1.5. The Licensor guarantees that the Work has not been published before the transfer of rights to it to the Licensee, and is not under consideration in publications and/or other media thematically similar to the publications and information products of the Licensee.

If a manuscript is found to have been submitted simultaneously to several editions, the published article will be retracted (withdrawn from publication).

 

  1. Rights and obligations of the Parties

 

2.1. The Licensor grants Licensee the following rights for the duration of the exclusive rights to the Work:

2.1.1. The right to reproduce the Work (duplication, replication or other reproduction of the Work) without limitation on the number of copies. At the same time, each copy of the Work shall contain the name of the author of the Work;

2.1.2. the right to distribute the Work by any means;

2.1.3. the right to be included in a composite work;

2.1.4. the right of public disclosure;

2.1.5. the use of metadata (title, author's (copyright holder's) name, abstracts, bibliographic materials, etc.) of the Works through distribution and communication to the public, processing and systematization, as well as inclusion in various databases and information systems.

2.1.6. the right to assign, on contractual terms, some or all of the rights obtained hereunder to third parties without payment of remuneration to the Licensor.

2.2. The Licensor transfers the rights to the Licensee under this Agreement on the basis of a non-exclusive license.

2.3. The Licensor shall provide the Licensee with the Work in electronic version in Word format for review within three business days. Within thirty (30) business days, if the Licensee has no claims or complaints against the Licensor related to the quality (content) or volume of the Work provided for review, the Parties shall sign the Acceptance Act of the Work.

2.4. The date of signing the Acceptance Act of the Work shall be the date of transfer to the Licensee of the rights set forth in this Agreement.

2.5. The Licensee undertakes to observe the copyrights provided by the current legislation, the rights of the Licensor, and to protect them and take all possible measures to prevent infringement of copyrights by third parties.

2.6. If the Licensor is a graduate student, he or she agrees on the final version of the manuscript with the supervisor.

2.7. The territory in which the rights to the Works may be used is all countries of the world without limitation.

2.8. The Licensor agrees to comply with the basic principles of the editorial policy:

  • research reported in the Work must be conducted in accordance with ethical and necessary legal standards;
  • research results must be presented clearly, honestly, without fabrication, falsification, tampering, or improper manipulation of data;
  • research methods should be described clearly and unambiguously, so that their conclusions have confirmation;
  • the submitted work must be original, not plagiarized, and not contain compilation fragments;
  • the authorship of a scientific publication (if there are coauthors) should accurately reflect the personal contribution of each coauthor to the work and its presentation in the publication;
  • funding sources and relevant conflicts of interest must be disclosed.

 

  1. Responsibility of the Parties

 

3.1. The Licensor and the Licensee shall be liable, in accordance with the applicable laws of the Russian Federation, for non-performance or improper performance of their obligations under this Agreement.

3.2. The Party that improperly performs or fails to perform its obligations under this Agreement shall be obliged to reimburse losses caused to the other Party, including lost profits.

 

  1. Concluding Provisions

 

4.1. Disputes and disagreements that may arise in the performance of this Agreement shall, if possible, be resolved through negotiations between the Parties.

4.2. If a dispute cannot be resolved through negotiations, the pre-trial (claim) procedure for dispute resolution shall apply. In such cases, the Party, whose right has been violated, shall be obliged to file a claim with the other Party, stating its requirements, before going to court. The deadline for responding to the claim shall be ten (10) business days from the date of its receipt.

4.3. If the disagreement cannot be resolved by negotiation or by claim procedure, disputes shall be considered in court at the plaintiff's location.

4.4. This Agreement shall enter into force upon its signing by both Parties and the Certificate of Acceptance of the Work, and shall remain in effect for the entire term of the exclusive rights to the Work.

4.5. This Agreement may be terminated at any time by mutual consent of the Parties, subject to the Parties signing an agreement to that effect.

4.6. This Agreement may be unilaterally terminated in cases provided for in the applicable laws of the Russian Federation, or by court order.

4.7. Any amendments and additions to this Agreement shall enter into force only if they are made in writing and signed by both Parties to this Agreement.

4.8. In all matters not provided for in this Agreement, the Parties shall be governed by the provisions of the applicable laws of the Russian Federation.

4.9. This Agreement has been drawn up in two copies of equal contents and legal force, one for each of the Parties.

 

Privacy Statement

Anonymity

Reviewer identities are not disclosed to authors or other reviewers unless the reviewer voluntarily signs their comments. Reviewers may disclose their names if they choose, in the interest of transparency. Authors, in turn, may opt for open peer review by leaving their identifying information in the manuscript upon submission.

Editing Reviewer Reports

As a rule, reviewer comments are not edited. All feedback is passed to the authors in its original form. In rare cases, we may modify wording to protect confidentiality or revise language that could be perceived as offensive. Reviewers are urged to maintain a professional tone and avoid personal remarks. At the same time, we encourage a clear and straightforward expression of critical opinions, while acknowledging that authors should recognize that direct critiques may not necessarily be unjustified.

 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».